PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Down 81.4% in August

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totaling 17,878 shares, a decrease of 81.4% from the August 15th total of 95,953 shares. Based on an average daily volume of 345,630 shares, the short-interest ratio is presently 0.1 days.

PharmaTher Trading Up 5.5%

Shares of PHRRF opened at $0.04 on Friday. The company has a 50-day moving average of $0.04 and a two-hundred day moving average of $0.05. PharmaTher has a one year low of $0.03 and a one year high of $0.30.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.